Our Mission

Sekbio is dedicated to providing high-quality IVD antibody raw materials and immunoreagents that enable accurate and reliable diagnostic testing worldwide. We believe in the power of innovation and quality to transform healthcare.

Our team of experienced scientists and engineers work tirelessly to develop and optimize antibodies for various IVD platforms including POCT, ELISA, CLIA, and FIA. With ISO 13485 certification, we ensure every product meets the highest quality standards.

Our Vision

To become the world's leading supplier of IVD antibody raw materials, recognized for our technical excellence, product reliability, and customer-centric approach. We aim to accelerate the development of next-generation diagnostic tests.

By investing in cutting-edge R&D and maintaining rigorous quality control, we continuously expand our product portfolio and support diagnostic manufacturers in bringing innovative tests to market faster.

Our Achievements

10+
Years of Experience
200+
Antibody Products
50+
Global Partners
99.9%
Customer Satisfaction

Our Core Values

Quality First

We never compromise on quality. Every product undergoes rigorous testing and quality control.

Innovation

Continuous R&D investment drives our ability to develop cutting-edge antibody solutions.

Customer Focus

Our customers' success is our success. We provide comprehensive technical support.

Integrity

We conduct business with transparency, honesty, and ethical principles.

Our Journey

2016

Company Founded

Sekbio was established in Shenzhen with a focus on IVD antibody development.

2018

First Product Launch

Successfully developed and launched our first POCT antibody product line.

2020

Platform Expansion

Expanded product portfolio to cover ELISA and CLIA platforms.

2022

ISO 13485 Certification

Achieved ISO 13485 certification for medical device quality management.

2024

Global Expansion

Established partnerships with diagnostic companies across Asia, Europe, and Americas.

2026

200+ Products

Reached milestone of 200+ antibody products in our portfolio.

Leadership Team

Mr. Jack Sun

Founder & CEO

Biology Degree, MBA, strategic investor, 20+ years experience in biotechnology industry.

Dr. David Chen

Chief Technology Officer

PhD in Biochemistry, leading R&D team for antibody development.

Mr. Nikhil Patel

Vice President, Sales

15+ years experience in IVD industry and global market development.

Our Capabilities

R&D Excellence

  • Monoclonal antibody development
  • Polyclonal antibody production
  • Recombinant protein expression
  • Antibody labeling & conjugation

Quality Assurance

  • ISO 13485 QMS
  • Batch-to-batch consistency
  • Full traceability
  • Stability testing

Technical Support

  • Assay development support
  • Technical consultation
  • Custom antibody development
  • 24/7 customer support

Join Our Team

We are always looking for talented individuals to join our growing team. If you are passionate about IVD and antibody development, we want to hear from you.

View Open Positions Contact HR